{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:22:14Z","timestamp":1750540934388},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We present images of a 50-year-old man who referred for treatment of a classic Hodgkin lymphoma. While <jats:sup>18<\/jats:sup>F-FDG PET\/CT demonstrated a complete metabolic remission after chemotherapy, an increased <jats:sup>18<\/jats:sup>F-FDG uptake of a right testicular lesion in <jats:sup>18<\/jats:sup>F-FDG PET\/CT and an unexplained bilateral gynecomastia were observed. A benign Leydig cell tumor was histopathologically proved after a right radical orchiectomy. The serum estradiol level was abnormally elevated reflecting the estrogen-secreting profile. This report highlights that a focal <jats:sup>18<\/jats:sup>F-FDG uptake in the testicular region with unexplained gynecomastia should suggest the diagnosis of an estrogen-secreting Leydig cell tumor on <jats:sup>18<\/jats:sup>F-FDG PET\/CT.<\/jats:p>","DOI":"10.1097\/rlu.0000000000001905","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T19:29:26Z","timestamp":1511378966000},"page":"41-43","source":"Crossref","is-referenced-by-count":4,"title":["Testicular Estrogen-Secreting Leydig Cell Tumor in 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"43","author":[{"given":"Axel","family":"Van Der Gucht","sequence":"first","affiliation":[{"name":"From the Departments of *Nuclear Medicine and Molecular Imaging, \u2020Oncology, \u2021Urology, and \u00a7Pathology and Laboratory Medicine, Lausanne University Hospital, Lausanne, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaher","family":"Maged","sequence":"additional","affiliation":[{"name":"From the Departments of *Nuclear Medicine and Molecular Imaging, \u2020Oncology, \u2021Urology, and \u00a7Pathology and Laboratory Medicine, Lausanne University Hospital, Lausanne, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Burruni","sequence":"additional","affiliation":[{"name":"From the Departments of *Nuclear Medicine and Molecular Imaging, \u2020Oncology, \u2021Urology, and \u00a7Pathology and Laboratory Medicine, Lausanne University Hospital, Lausanne, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Barras","sequence":"additional","affiliation":[{"name":"From the Departments of *Nuclear Medicine and Molecular Imaging, \u2020Oncology, \u2021Urology, and \u00a7Pathology and Laboratory Medicine, Lausanne University Hospital, Lausanne, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklaus","family":"Schaefer","sequence":"additional","affiliation":[{"name":"From the Departments of *Nuclear Medicine and Molecular Imaging, \u2020Oncology, \u2021Urology, and \u00a7Pathology and Laboratory Medicine, Lausanne University Hospital, Lausanne, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.juro.2009.02.051","article-title":"Leydig cell tumor of the testis","volume":"181","year":"2009","journal-title":"J Urol"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.juro.2007.05.077","article-title":"Long-term followup after elective testis sparing surgery for Leydig cell tumors: a single center experience","volume":"178","year":"2007","journal-title":"J Urol"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1014481609336","article-title":"Leydig cell tumour\u2014a rare testicular tumour","volume":"33","year":"2002","journal-title":"Int Urol Nephrol"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1464-410X.2008.08016.x","article-title":"Leydig cell tumour of the testis: presentation, therapy, long-term follow-up and the role of organ-sparing surgery in a single-institution experience","volume":"103","year":"2009","journal-title":"BJU Int"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.clgc.2012.12.008","article-title":"Long-term follow-up using testicle-sparing surgery for Leydig cell tumor","volume":"11","year":"2013","journal-title":"Clin Genitourin Cancer"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/RLU.0b013e3181cc6467","article-title":"F-18 FDG PET\/CT imaging of a Leydig cell tumor","volume":"35","year":"2010","journal-title":"Clin Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00280-005-0181-6","article-title":"Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumor","volume":"58","year":"2006","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201801000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:03:19Z","timestamp":1695618199000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201801000-00012"}},"subtitle":["An Incidental Detection in a Patient Treated by Chemotherapy for Hodgkin Lymphoma"],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001905","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}